MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancerStephen Johnston(Royal Marsden NHS Foundation Trust), Matthew P. Goetz(Mayo Clinic in Arizona)npj Breast CancerJanuary 11, 201910.1038/s41523-018-0097-zCited by 673SaveCiteExport RISWatch citationsRelated PapersEndoxifen downregulates AKT phosphorylation through protein kinase C beta 1 inhibition in ERα+ breast cancer|npj Breast Cancer|2023|10